NCT05377476Completed
Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis
Investigation of the Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 19 Dec 2025
Brief summary (registry, in English)
It was planned to examine the effects of motor imagery and action observation applied in addition to standard rehabilitation in people with multiple sclerosis on walking, fatigue, and trunk control.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 12 May 2022
- Start date
- 1 Jun 2022
- Primary completion date
- 1 Apr 2024
- Lead sponsor
- Hacettepe University
- Diseases
- Multiple sclerosis
- NCT number
- NCT05377476
What you commit to
- Study type: Interventional
- Participants enrolled: 48
- From 1 Jun 2022 to the primary completion date, 1 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score of less than 24
- Having another musculoskeletal, cardiovascular, pulmonary, metabolic, or neurological disease severe enough to preclude participation in the study.
Other
- Having severe vision and hearing problems
Who the study is looking for
- Being between the ages of 18-65
- A definitive diagnosis of MS by a neurologist according to the 2017 McDonald Criteria
- Expanded Disability Status Scale (EDSS) score of 4.0 and below (it is determined routinely by the physician during the examination)
- Not having an attack in the last 3 months
- A minimum score of 4 in each motor imagery ability (internal visual imagery, external visual imagery, and kinesthetic imagery) on the Movement Imagery Questionnaire-3 (MIQ-3)
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hacettepe University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.